Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Griswold

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cancer|September 15, 1984
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacologyF M Schabel, D P Griswold, T H Corbett, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
The preclinical scientific basis for adjuvant chemotherapy in breast cancerD P Griswold, W R Laster, M W Trader, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Absence of delayed lethality in mice treated with aclacinomycin AT H Corbett, D P Griswold, B J Roberts, et al.
Journal of the National Cancer Institute|April 11, 1992
Excision assay for initial evaluation of antitumor drug activity in mice bearing human tumor xenograftsD J Dykes, S D Harrison, J G Mayo, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosineL J Wilkoff, D A Dulmadge, W R Laster, et al.
Journal of the National Cancer Institute|August 1, 1987
Experimental antitumor activity of the amsacrine analogue CI-921W R Leopold, T H Corbett, D P Griswold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.
Cancer Research|April 15, 1991
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.
Cancer Research|September 11, 1975
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structureT H Corbett, D P Griswold, B J Roberts, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cancer|September 15, 1984
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacologyF M Schabel, D P Griswold, T H Corbett, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
The preclinical scientific basis for adjuvant chemotherapy in breast cancerD P Griswold, W R Laster, M W Trader, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Absence of delayed lethality in mice treated with aclacinomycin AT H Corbett, D P Griswold, B J Roberts, et al.
Journal of the National Cancer Institute|April 11, 1992
Excision assay for initial evaluation of antitumor drug activity in mice bearing human tumor xenograftsD J Dykes, S D Harrison, J G Mayo, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosineL J Wilkoff, D A Dulmadge, W R Laster, et al.
Journal of the National Cancer Institute|August 1, 1987
Experimental antitumor activity of the amsacrine analogue CI-921W R Leopold, T H Corbett, D P Griswold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.
Cancer Research|April 15, 1991
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.
Cancer Research|September 11, 1975
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structureT H Corbett, D P Griswold, B J Roberts, et al.
Pageof 6